SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-02-011721
Filing Date
2002-12-12
Accepted
2002-12-11 19:07:02
Documents
5
Period of Report
2002-09-30

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. y66571e10vk.txt 10-K 386897
3 SUBSIDIARY y66571exv21.txt EX-21 229
4 CONSENT OF KPMG LLP y66571exv23.txt EX-23 1806
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER y66571exv99w1.txt EX-99.1 1444
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER y66571exv99w2.txt EX-99.2 1448
  Complete submission text file 0000950123-02-011721.txt   393959
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-15190 | Film No.: 02855148
SIC: 2835 In Vitro & In Vivo Diagnostic Substances